Use of cyproterone acetate in animal and clinical trials.
D000726:Androgen Antagonists; D000818:Animals; D001827:Body Height; D001846:Bone Development / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D003276:Contraceptives, Oral; D003534:Cyproterone / Q000494:pharmacology / Q000627:therapeutic use; D004822:Epididymis / Q000187:drug effects; D005260:Female; D006066:Gonads / Q000187:drug effects; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D011245:Pregnadienes; D011247:Pregnancy; D011467:Prostate / Q000187:drug effects; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011629:Puberty, Precocious / Q000188:drug therapy; D012627:Sebaceous Glands / Q000187:drug effects; D012669:Seminal Vesicles / Q000187:drug effects; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D013739:Testosterone / Q000502:physiology
D000726:Androgen Antagonists; D003276:Contraceptives, Oral; D011245:Pregnadienes; D013739:Testosterone; D003534:Cyproterone